1
Home
Companies

PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals
Leadership team

Ashutosh Chilkoti (Founder)

Clay B. Thorp (Founder)

Products/ Services
Biotechnology, Medical, Medical Device, Pharmaceutical
Number of Employees
50 - 100
Headquarters
Malvern, Pennsylvania, United States
Established
2002
Company Registration
SEC CIK number: 0001169245
Traded as
NASDAQ:PHAS
Social Media
URL
www.phasebio.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
PhaseBio Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat cardiovascular and metabolic diseases. We are developing novel therapies based on our peptide technology platform that utilizes peptide-based biologic drugs with the potential to act locally, targeting specific tissue populations or pathways to modulate their activity.
History

PhaseBio Pharmaceuticals was founded in 2007 and is headquartered in San Francisco, CA. The company is focused on developing peptide-based therapies for the treatment of cardiovascular and metabolic diseases, encouraging safe use of established therapies and clinical needs resulting from inefficient new therapeutic indications. Furthermore, PhaseBio pursues sustained clinical success and innovative approaches to build a robust pipeline of drugs.

Mission
Our mission is to develop novel therapies based on our peptide technology platform to improve the lives of patients with cardiovascular and metabolic diseases, ultimately providing value to all of our stakeholders.
Vision
Our vision is to be a global leader in improving the quality of life for patients with cardiovascular and metabolic diseases.
Key Team

Ashutosh Chilkoti (Founder)

Clay B. Thorp (Founder)

Recognition and Awards
PhaseBio is the recipient of numerous awards and recognitions, including the National Institute of Health’s 2017 Transformative Breakthrough Prize in Single Molecule Design and the 2016 MassBio Pharma Startup of the Year award.
References

https://in.investing.com/equities/phasebio-pharmaceuticals

https://www.crunchbase.com/organization/phasebio-pharmaceuticals

www.phasebio.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

PhaseBio Pharmaceuticals
Leadership team

Ashutosh Chilkoti (Founder)

Clay B. Thorp (Founder)

Products/ Services
Biotechnology, Medical, Medical Device, Pharmaceutical
Number of Employees
50 - 100
Headquarters
Malvern, Pennsylvania, United States
Established
2002
Company Registration
SEC CIK number: 0001169245
Traded as
NASDAQ:PHAS
Social Media
URL
www.phasebio.com